Health-related quality of life in undergraduate women using any contraceptive
- PMID: 31126343
- PMCID: PMC6534913
- DOI: 10.1186/s12955-019-1157-2
Health-related quality of life in undergraduate women using any contraceptive
Abstract
Objective: The aim of this research was to assess university students' health-related quality of life whether they use some contraceptive method or not.
Methods: This research is a cross-sectional study. Female participants who studied a degree in health at the University of Seville (Spain) were recruited. Respondents completed a demographic questionnaire and health-related quality of life was measured with validated instrument SEC-QoL (Sociedad Española de Contracepción- Quality of Life) in Spanish that measured five dimensions: sexual, social, breast, menstrual and psychosocial.
Results: A total of 992 women aged 21.37 (3.6) years old participated in this study. Women who used a contraceptive method reached higher scores at the SEC-QoL questionnaire 47.09 (17.04) and 46.91 (18.73) than those that didn't. Likewise, women who chose a hormonal method showed a better overall health-related quality of life, compared to those who used a non-hormonal method. Participants who used hormonal contraceptives obtained higher scores in all health-related quality of life domains (social, menstrual, breast and sexual), except psychological domain when compared to those who used a non hormonal method or none. Furthermore, a moderated mediation model showed that the effect of the current contraceptive method on health-related quality of life was partially explained by the moderated mediation of the time using this method, the reason for using it and the existence of a partner.
Conclusion: The usage of hormonal contraceptives increases health-related quality of life in young women. Several variables regarding the experience with contraceptive methods should be considered in order to examine the effect on health-related quality of life in undergraduate women.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
One year quality of life measured with SEC-QoL in levonorgestrel 52 mg IUS users.Contraception. 2016 Apr;93(4):367-371. doi: 10.1016/j.contraception.2015.12.014. Epub 2016 Jan 4. Contraception. 2016. PMID: 26764120
-
Factors related to healthy sexual and contraceptive behaviors in undergraduate students at university of Seville: a cross- sectional study.Reprod Health. 2017 Dec 29;14(1):179. doi: 10.1186/s12978-017-0444-9. Reprod Health. 2017. PMID: 29284505 Free PMC article.
-
Development and validation of the SEC-QOL questionnaire in women using contraceptive methods.Value Health. 2011 Sep-Oct;14(6):892-9. doi: 10.1016/j.jval.2011.08.1729. Value Health. 2011. PMID: 21914511
-
Canadian Contraception Consensus (Part 1 of 4).J Obstet Gynaecol Can. 2015 Oct;37(10):936-42. doi: 10.1016/s1701-2163(16)30033-0. J Obstet Gynaecol Can. 2015. PMID: 26606712 English, French.
-
A Biopsychosocial Model for the Counseling of Hormonal Contraceptives: A Review of the Psychological, Relational, Sexual, and Cultural Elements Involved in the Choice of Contraceptive Method.Sex Med Rev. 2019 Oct;7(4):587-596. doi: 10.1016/j.sxmr.2019.06.005. Epub 2019 Jul 24. Sex Med Rev. 2019. PMID: 31351917
Cited by
-
Influence of menstrual pain and symptoms on activities of daily living and work absenteeism: a cross-sectional study.Reprod Health. 2024 Feb 19;21(1):25. doi: 10.1186/s12978-024-01757-6. Reprod Health. 2024. PMID: 38374080 Free PMC article.
-
Use of modern family planning methods and its association with quality of life among Rwandan women: a multi-center cross-sectional study.Contracept Reprod Med. 2025 Aug 15;10(1):50. doi: 10.1186/s40834-025-00374-3. Contracept Reprod Med. 2025. PMID: 40813710 Free PMC article.
-
Risk Factors for Low Quality of Life among Women Using Different Types of Contraceptives in Saudi Arabia: A Questionnaire-Based Study.Behav Sci (Basel). 2024 Sep 17;14(9):829. doi: 10.3390/bs14090829. Behav Sci (Basel). 2024. PMID: 39336044 Free PMC article.
-
Use of estrogen supplementation is associated with higher quality of life scores in women with cystic fibrosis.J Clin Transl Endocrinol. 2021 Dec 11;27:100292. doi: 10.1016/j.jcte.2021.100292. eCollection 2022 Mar. J Clin Transl Endocrinol. 2021. PMID: 34976742 Free PMC article.
References
-
- Lopez LM, Kaptein AA, Helmerhorst FM. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database of Systematic Reviews 2012, Issue 2. Art. No.: CD006586. doi:10.1002/14651858.CD006586.pub4. - PubMed
-
- Fraser IS, Kovacs GT. The efficacy of non-contraceptive uses for hormonal contraceptives. Med J Aust. 2003;178(12):621–623. - PubMed